Cardiff Oncology (CRDF) Net Margin (2011 - 2026)
Cardiff Oncology (CRDF) recorded Net Margin of -8882.69% in Q2 2026, up 2645.41 percentage points from -11528.10% a year earlier.
Cardiff Oncology (CRDF) Net Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Cardiff Oncology's Net Margin came in at -7087.41% as of Jun 30, 2026, up 2261.12 percentage points year-over-year; for FY2025, it came in at -7736.26%, down 1081.06 percentage points from FY2024.
- Annual Net Margin has a five-year change of -1561.94 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -6655.20% in FY2024 (+1841.73 pp), -8496.93% in FY2023 (+1536.23 pp), -10033.16% in FY2022 (-2145.97 pp) and -7887.19% in FY2021 (-1712.87 pp).
- Quarterly Net Margin has ranged from -14863.51% in Q1 2022 to -2972.43% in Q4 2025 over the past five years.
- On a year-over-year basis, Net Margin rose in two of the last seven quarters, with an average year-over-year change of -1223.07 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 8642.57 percentage points in Q1 2024, against a drop of 7662.12 percentage points in Q1 2022 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,162.99 Bn | 1,131.58 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 633.71 Bn | 552.23 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 502.40 Bn | 475.51 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 376.48 Bn | 330.86 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 267.02 Bn | 240.70 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 240.85 Bn | 196.25 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 193.39 Bn | 167.58 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | -1.65% |
| 10 | Cardiff Oncology | 66.35 Mn | 31.85 Mn | - | -8,882.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8,882.69% |
| Dec 31, 2025 | -2,972.43% |
| Sep 30, 2025 | -9,386.67% |
| Jun 30, 2025 | -11,528.10% |
| Mar 31, 2025 | -12,330.28% |
| Dec 31, 2024 | -7,809.93% |
| Sep 30, 2024 | -7,188.48% |
| Jun 30, 2024 | -7,229.45% |
| Mar 31, 2024 | -4,886.34% |
| Dec 31, 2023 | -5,989.10% |
| Sep 30, 2023 | -6,905.67% |
| Jun 30, 2023 | -10,329.63% |
| Mar 31, 2023 | -13,528.92% |
| Dec 31, 2022 | -6,799.22% |
| Sep 30, 2022 | -9,222.58% |
| Jun 30, 2022 | -11,482.42% |
| Mar 31, 2022 | -14,863.51% |
| Dec 31, 2021 | -7,103.76% |
| Sep 30, 2021 | -8,045.35% |
| Jun 30, 2021 | -9,945.59% |
Cardiff Oncology Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CRDF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();